ZNF518B and colorectal carcinoma: In an effort to understand the molecular causes of the involvement of ZNF518B in CRC progression and EMT, in the present paper, we first examine whether the differential expression of isoforms 1 and 2 is related to any phenotypic characteristic of CRC patients, and then show our results, which found that the lower the ratio of isoform 2/isoform 1, the higher the probability of relapsing.